Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00863200 · ClinicalTrials.gov registry record
Identification and Treatment of Depression
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 134
- Enrollment target
NCT00863200: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00863200 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00863200 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The goal of this research study is to learn how well a telephone system works for improving the management of emotional distress, sadness, and/or depression in patients who are being treated for cancer.
Interventions
- BEHAVIORAL Telephone Intervention
- BEHAVIORAL Questionnaires & Interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2009-03 |
| Est. Completion | 2019-02-12 |
What the finished NCT00863200 record still lists
NCT00863200 is an observational study that tracks outcomes without assigning an intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Telephone Intervention is the first listed.
NCT00863200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00863200 about?
NCT00863200 is a clinical study titled "Identification and Treatment of Depression". The goal of this research study is to learn how well a telephone system works for improving the management of emotional distress, sadness, and/or depression in patients who are being treated for cancer.
What is the current status of trial NCT00863200?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2009-03. Estimated completion is 2019-02-12.
What interventions are being tested in trial NCT00863200?
The interventions under investigation include: Telephone Intervention (BEHAVIORAL), Questionnaires & Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT00863200?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia